Pacific Biosciences of California, Inc. (PACB): Operating Income
-$553.86M
Year ended 2025-12-31
-$133.04M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$553.86M | n/m | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | -$474.31M | n/m | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | -$334.47M | n/m | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | -$307.20M | n/m | 2025-03-17, From 2022-01-01 |
| 2021-12-31 | -$210.44M | n/m | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | -$104.39M | n/m | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | -$100.55M | n/m | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | -$100.99M | n/m | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | -$89.78M | n/m | 2020-02-28, From 2017-01-01 |
| 2016-12-31 | -$71.24M | n/m | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | -$29.13M | n/m | 2018-02-26, From 2015-01-01 |
| 2014-12-31 | -$62.85M | n/m | 2017-03-06, From 2014-01-01 |
| 2013-12-31 | -$77.54M | n/m | 2016-03-11, From 2013-01-01 |
| 2012-12-31 | -$94.34M | n/m | 2015-03-12, From 2012-01-01 |
| 2011-12-31 | -$109.76M | n/a | 2014-03-14, From 2011-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | -$553.86M | n/m |
| Quanterix Corp (QTRX) | 2025-12-31 | -$125.54M | n/m |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | -$40.38M | n/m |
| Harvard Bioscience Inc (HBIO) | 2025-12-31 | -$48.58M | n/m |
| 908 Devices Inc. (MASS) | 2025-12-31 | -$39.42M | n/m |
| 10x Genomics, Inc. (TXG) | 2025-12-31 | -$60.98M | n/m |
| Rapid Micro Biosystems, Inc. (RPID) | 2025-12-31 | -$47.39M | n/m |
| EyePoint, Inc. (EYPT) | 2025-12-31 | -$243.43M | n/m |
| Bionano Genomics, Inc. (BNGO) | 2025-12-31 | -$33.34M | n/m |
Compare PACB, QTRX, CTKB, HBIO side by side · Screen every company in Laboratory Analytical Instruments ↗